Home > Journals > Minerva Anestesiologica > Past Issues > Minerva Anestesiologica 2002 November;68(11) > Minerva Anestesiologica 2002 November;68(11):855-9

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA ANESTESIOLOGICA

A Journal on Anesthesiology, Resuscitation, Analgesia and Intensive Care


Official Journal of the Italian Society of Anesthesiology, Analgesia, Resuscitation and Intensive Care
Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 2,623


eTOC

 

CLINICAL CASES  CRITICAL CAREFREEfree


Minerva Anestesiologica 2002 November;68(11):855-9

Copyright © 2009 EDIZIONI MINERVA MEDICA

language: English, Italian

Role of desmopressin in the treatment of a case of septic shock refractory to catecholamines

Mignani V., Poleggi P., Conti G., Pennisi M. A., Marchese M.

Department of Anesthesia and Resuscitation Catholic University of the Sacred Heart, Rome


FULL TEXT  


The ­authors ­describe a ­case of sep­tic ­shock refrac­to­ry to ­high-­dose cat­e­chol­a­mines ­after ade­quate volem­ic fill­ing, rap­id­ly cor­rect­ed ­with the admin­is­tra­tion of desmo­pres­sin at a ­dose of 0.02 U/min. ­There are, in the lit­er­a­ture, sev­er­al cas­es of sep­tic ­shock refrac­to­ry to ­high-­dose cat­e­chol­a­mines suc­cess­ful­ly treat­ed ­with argi­nine-vas­o­pres­sin, a selec­tive V1 ago­nist. ­This ­agent can poten­tial­ly ­induce cor­o­nary vaso­con­stric­tion and ­presents a ­very dif­fi­cult wean­ing, ­that impos­es a ­slow reduc­tion of the infu­sion ­amount. On the con­trary, desmo­pres­sin ­does not ­present ­those ­adverse ­effects and is ­able to main­tain a ­high ­renal ­blood ­flow, for its prev­a­lent ­action on V2 ­instead of V1 recep­tors.

top of page

Publication History

Cite this article as

Corresponding author e-mail